Filters: Author is S Blower [Clear All Filters]
Mathematicians turn their attention to hepatitis C. Nat Med. 4:1233-4.. 1998.
Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemics. J Infect Dis. 190:1610-7.. 2004.
Modeling the potential public health impact of imperfect HIV vaccines. J Infect Dis. 192:1494-5;authorreply1495-6.. 2005.
Predicting the future of XDR tuberculosis. Lancet Infect Dis. 7:443.. 2007.
Transmission of zidovudine resistant strains of HIV-1: the first wave. AIDS. 15:2317-8.. 2001.
Epidemiology, HIV and drugs: mathematical models and data. Br J Addict. 87:371-9.. 1992.
Calculating the contribution of herpes simplex virus type 2 epidemics to increasing HIV incidence: treatment implications. Clin Infect Dis. 39 Suppl 5:S240-7.. 2004.
Treatment Equity & the HIV epidemic in Africa. Nuntium by Bishop Rino Fisichella, Rector of the Pontifical Lateran University, Auxiliary of Rome, Pontifical Lateran University, The Vatican. 34. 2010.
Calculating the consequences: HAART and risky sex. AIDS. 15:1309-10.. 2001.
Behaviour change and stabilization of seroprevalence levels in communities of injecting drug users: correlation or causation? J Acquir Immune Defic Syndr. 4:920-3.. 1991.
Predicting the impact of antiretrovirals in resource-poor settings: preventing HIV infections whilst controlling drug resistance. Curr Drug Targets Infect Disord. 3:345-53.. 2003.
HIV, drugs, and ecology. Science. 246:1236.. 1989.
What can modeling tell us about the threat of antiviral drug resistance? Curr Opin Infect Dis. 15:609-14.. 2002.
Modelling the genital herpes epidemic. Herpes. 11 Suppl 3:138A-146A.. 2004.
Is population-level perversity a likely outcome of mass vaccination against HIV? - Authors reply Lancet Infect Dis. 5:255-256.. 2005.
Sex and sample size. Lancet. 341:1023.. 1993.
Response. Science. 267:1252-3.. 1995.
Antibiotic resistance–to treat...(or not to treat)? Nat Med. 5:358.. 1999.
Modeling the potential impact of rectal microbicides to reduce hiv transmission in bathhouses. Math Biosci Eng. 3:459-66.. 2006.
Reply to "Comment on 'Linking population-level models with growing networks: a class of epidemic models'". Phys Rev E Stat Nonlin Soft Matter Phys. 74:046110.. 2006.
Quantifying the treatment efficacy of reverse transcriptase inhibitors: new analyses of clinical data based on within-host modeling. BMC Public Health. 9 Suppl 1:S11.. 2009.